Management of HPV-16 Positive Women

Rationale for Immediate Colposcopy

The American Society for Colposcopy and Cervical Pathology recommends immediate colposcopy for women with HPV-16 or HPV-18 positivity, regardless of cytology results, due to the significantly elevated risk of high-grade cervical intraepithelial neoplasia (CIN 3) and cervical cancer 1
HPV-16 infection in women aged 30 and older with negative cytology carries a 17-21% 10-year cumulative risk of developing CIN 3 or worse, which is substantially higher than the 3% risk associated with other high-risk HPV types and the 1.5% risk in women with non-16/18 high-risk HPV types 3, 4

At the time of colposcopy, endocervical sampling is preferred to evaluate for endocervical lesions that may not be visible on colposcopic examination, as recommended by the American College of Obstetricians and Gynecologists 2
Colposcopically-directed biopsies should be obtained from any visible lesions after application of 3-5% acetic acid solution, according to the American Journal of Obstetrics and Gynecology 5

If CIN 2 or CIN 3 is identified, treatment with excisional procedure (LEEP or cold-knife conization) or ablation is indicated, as recommended by the National Comprehensive Cancer Network 3
Post-treatment surveillance should continue for at least 25 years with HPV testing or co-testing at 6, 18, and 30 months, according to the American Society for Colposcopy and Cervical Pathology 7

The American College of Obstetricians and Gynecologists advises against delaying colposcopy based on negative cytology alone, as the combination of HPV-16 positivity significantly elevates risk regardless of cytology 2